SEC Info - BioCardia, Inc. - ‘S-3/A’ on 6/28/17

SEC Info℠

Home

Help

Please Sign In

BioCardia, Inc. – ‘S-3/A’ on 6/28/17 – ‘EX-24.2’

On: Wednesday, 6/28/17, at 5:24pm ET · Accession #: 1437749-17-11918 · File #: 333-218124

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 6/28/17  BioCardia, Inc.                   S-3/A                  4:1.3M                                   RDG Filings/FA

Pre-Effective Amendment to Registration Statement for Securities Offered Pursuant to a Transaction — Form S-3
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-3/A       Pre-Effective Amendment to Registration Statement   HTML    365K 
                          for Securities Offered Pursuant to a                   
                          Transaction                                            
 2: EX-5.1      Opinion re: Legality                                HTML     27K 
 3: EX-23.1     Consent of Experts or Counsel                       HTML      6K 
 4: EX-24.2     Power of Attorney                                   HTML      8K

EX-24.2 — Power of Attorney

This exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

Exhibit 24.2

Power of Attorney

Allan R. Tessler hereby appoints Peter Altman and David McClung, and each of them individually, as his true and lawful attorneys-in-fact and agents with full power of substitution and resubstitution, for his and in his name, place and stead, in any and all capacities, including in particular, as a Director of BioCardia, Inc. (the “Company”) to sign any or all amendments to that certain Registration Statement on Form S-3 filed with the Securities and Exchange Commission (the “SEC”) by the Company on May 19, 2017 (File No. 333-218124) (including pre and post-effective amendments and registration statements filed pursuant to Rule 462(b) under the Securities Act of 1933, as amended, and otherwise), and to file the same, with all exhibits thereto, and other documents in connection therewith, with the SEC granting unto said attorneys-in-fact and agents the full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the foregoing, as full to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or his substitute, may lawfully do or cause to be done by virtue thereof.


	Date: 6/26/2017

	By:		/s/ *Allan R. Tessler*
	Name:		Allan R. Tessler
	Title:		Director, BioCardia, Inc.

Dates Referenced Herein and Documents Incorporated by Reference

This ‘S-3/A’ Filing	Date	Other Filings

Filed on:	6/28/17
	5/19/17	S-3
		List all Filings

↑Top

Filing Submission 0001437749-17-011918 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)